Hemodynamic Support Devices

This hemodynamic support systems channel includes content on intra-aortic balloon pumps (IABP), percutaneous ventricular assist devices (pVAD) like the Impella or TandemHeart, extracorporeal membrane oxygenation (ECMO), and ventricular assist devices (VAD). This channel also includes use of these devices in support of patients in cardiogenic shock and advanced heart failure.

With the addition of Pulse Wave Doppler [1], Philips has greatly expanded the utility of its Handheld Ultrasound – Lumify – enabling clinicians to quantify blood flow in a wide range of point-of-care diagnostic applications – including cardiology, vascular, abdominal, urology, obstetrics and gynecology.

News | Point-of-Care Ultrasound (POCUS)

Philips Expands Ultrasound Portfolio with Handheld POCUS

February 9, 2022 — Philips, a global leader in health technology, announced it has expanded its ultrasound portfolio wit ...

February 09, 2022

Extracorporeal membrane oxygenation (ECMO) is a lifesaving treatment for critically ill neonates. But there has been little data published on which of these patients are more likely to be readmitted to the hospital later on.

News | ECMO Systems

Researchers Identify Factors That May Help Predict Which Neonatal ECMO Patients Will Have to Return to the Hospital

February 8, 2022 — Extracorporeal membrane oxygenation (ECMO) is a lifesaving treatment for critically ill neonates ...

February 08, 2022

Videos | Heart Failure

VIDEO: Details on the First Pig Heart Transplant Surgery in a Human

The University of Maryland Medical Center (UMMC) announced the first successful transplant of a genetically modified pig ...

January 11, 2022

The first pig heart to be transplanted into a human is moved from a perfusion transport system to the patient during the groundbreaking procedure January 7, 2022. This is the first human to receive a pig heart transplant. #Pigheart

Feature | Heart Failure | By Dave Fornell, DAIC Editor

First Human Receives a Pig Heart Transplant

January 10, 2022 — The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center ...

January 10, 2022

The most popular videos in 2021 included the use of ECMO for COVID-19 patients, a demonstration of the Medis QFR angiography image derived FFR system, and the use of remote EP monitoring systems.

Feature

December 26, 2021 — Here is a list of the most popular videos on the DAIC website from the past year in 2021 based on ...

December 26, 2021

News | Intra-Aortic Balloon Pumps (IABP)

Cardiosave Hybrid and Cardiosave Rescue IABPs Recalled Due to Reports of Fluid Leaks

December 16, 2021 — Datascope/Getinge/Maquet has recalled the Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic ...

December 16, 2021

Staff member sets up an ECMO unit for a severely ill COVID-19 patient at Banner Health in Phoenix. A new study shows there is minimal safety risk in transporting patients who need ECMO to a hospital that can provide it as long as PPE requirements and other safety guidelines are met. #COVID19 #SARSCoV2 #ECMO

News | Coronavirus (COVID-19)

No Extra COVID-19 Risk for ECMO Transport Teams

December 7, 2021 – Critically ill patients with COVID-19 can safely be transported for lifesaving extracorporeal ...

December 07, 2021

Videos | Cardiogenic Shock

VIDEO: Updates Made to the SCAI Cardiogenic Shock Classifications

Srihari Naidu, M.D., FACC, FAHA, FSCAI, is the director of both the cardiac cath labs and Hypertrophic Cardiomyopathy ...

November 16, 2021

Cardiosave Hybrid Intra-Aortic Balloon Pump (IABP) left, and the Cardiosave Rescue Intra-Aortic Balloon Pump. Both systems have a recall because of reports that the battery can fail.

News | Intra-Aortic Balloon Pumps (IABP)

Cardiosave Intra-Aortic Balloon Pumps Recalled Due to Battery Failure

November 2, 2021 — Datascope/Getinge/Maquet is recalling its Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pumps (IABP) ...

November 02, 2021

The CorWave LVAD uses a pulse pump rather than a rotary pump to move blood, so it more closely simulates the movement of blood in a read heart.

News | Ventricular Assist Devices (VAD)

Innovative New Pulsatile LVAD Wins 2021 HealthTech Award

October 20, 2021 – CorWave, a French medtech company developing a next-generation heart pump, won the 2021 HealthTech ...

October 20, 2021

Cardiothoracic surgeons with UofL Health – Jewish Hospital and the University of Louisville performed the world’s first Carmat Aeson bioprosthetic total artificial heart implantation in a female patient on Sept. 14, 2021. The device was small enough to fit into the woman's smaller chest cavity. The device is being tested as a bridge to heart transplant rather than use of a LVAD. Photo by UofL Health.

News | Heart Failure

First Woman in World Receives New Type of Artificial Heart

September 22, 2021 — A cardiothoracic surgical team with University of Louisville Health – Jewish Hospital has performed ...

September 22, 2021

A nurse at Banner Health ion Phoenix, Ariz., adjusts an ECMO unit being used to support a severely ill COVID-19 patient. A new study finds high levels of moral distress among clinicians who regularly care for patients receiving mechanical circulatory support such as ECMO.

News | ECMO Systems

Growing Use of Mechanical Circulatory Support Affects Clinician Well-Being, Moral Distress

September 13, 2021 — The growing use of mechanical circulatory support (MCS) may contribute to high levels of moral ...

September 13, 2021

Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular assist device (LVAD). Abbott announced the same day it has the capacity to meet increased demand for LVADs as Medtronic leaves the market.

Feature | Ventricular Assist Devices (VAD) | By Dave Fornell, Editor

Medtronic Ends Sales of HVAD Ventricular Assist System

Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular ...

July 08, 2021

The Carmat system, an experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure. Outcomes in the first series of patients managed with the new heart replacement pump in Auto-Mode are presented in the journal of the American Society for Artificial Internal Organs (ASAIO).

News | Artificial Heart

Carmat Artificial Heart Shows Promising Automatic Regulation of Blood Flow

June 18, 2021 – An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can ...

June 23, 2021

News | Antiplatelet and Anticoagulation Therapies

FDA Clears Pradaxa as First Oral Anticoagulant for Children

June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate ...

June 21, 2021